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ABSTRACT 
Cytosine  arabinoside  (Ara-C)  elicits  a  significant  increase  in  the  level  of the 
enzyme glutamine synthetase (GS) while it markedly reduces overall RNA and 
protein synthesis in cultures of embryonic chick neural retina. This increase was 
analyzed by radioimmunochemical procedures and compared with the induction 
of GS by hydrocortisone (HC). Accumulation of GS in Ara-C-treated retinas was 
found to be due to de novo synthesis of the enzyme; however, unlike the induction 
of GS by HC, Ara-C caused no measurable increase in the rate of GS synthesis. 
The results indicate that Ara-C facilitates GS accumulation largely by preventing 
degradation  of  the  enzyme.  Even  though  Ara-C  inhibits  the  bulk  of  RNA 
synthesis  in  the  retina,  it  does  not  stop  the  formation  of  GS-specific  RNA 
templates.  However, the  progressive accumulation of these  templates does not 
result in an increased rate of GS synthesis unless Ara-C is withdrawn from such 
cultures  under  suitable  experimental conditions.  Thus,  it  is  suggested  that  the 
continuous presence of Ara-C imposes a reversible hindrance at the translational 
level  which  limits  the  rate  of GS  synthesis.  The  results  demonstrate  that  the 
increase in retinal GS elicited by Ara-C is achieved through mechanisms which are 
quite different from those involved in the hydrocortisone-mediated induction of 
this enzyme. 
During  embryonic differentiation,  genotypically 
identical  cells undergo alterations in  patterns of 
specific  macromolecular synthesis  and  thus  be- 
come  phenotypically  diverse.  An  experimental 
system  which has proven useful  for investigating 
mechanisms  governing differential gene  expres- 
sion in embryonic ceils is the retina-specific induc- 
tion of the enzyme glutamine synthetase (GS) (EC 
6.3.1.2)  by  hydrocortisone (HC)  in  cultures  of 
embryonic chick neural retina tissue (for reviews~ 
see  references 25-27,  37).  These  studies  have 
shown that GS induction involves: (a) complexing 
of  the  steroid  with  cytoplasmic  receptors,  (b) 
binding of these complexes to sites in the nucleus, 
(c) transcriptional  and posttranscriptional modifi- 
cations, and (d) an increased rate of synthesis and 
accumulation  of the enzyme (20, 26, 27, 29, 30, 
34). 
Recently it has been found that relatively high 
concentrations of 1-/3-D-arabinofuranosylcytosine 
30  THE  JOURNAL OF CELL BIOLOGY ￿9  VOLUME 74,  1977 ￿9 pages 30-42 (cytosine arabinoside;  Ara-C) which inhibit RNA 
synthesis  in the retina by  -80%  can elicit a  sev- 
eral-fold increase in retinal GS activity in the ab- 
sence of the steroid inducer (15, 28). This effect of 
Ara-C is dependent upon specific sites on both the 
sugar  and  pyrimidine  moieties of the  molecule. 1 
Investigations of the mechanism  of Ara-C action 
in the retina have demonstrated  that this effect is 
not related to the conventional action of Ara-C as 
an  inhibitor  of DNA  synthesis  (7,  42).  The  evi- 
dence suggested that,  under these conditions, the 
nucleoside  acts  primarily  through  transcriptional 
processes  which  indirectly  lead  to  the  provision 
and  accumulation  of template  RNA essential for 
the  subsequent  synthesis  of  GS  (14,  15).  More- 
over, in the preceding paper of this series (15), the 
possibility was raised  that  Ara-C may also  act  at 
translational or post-translational levels of control. 
Previous  measurements  of GS  specific activity 
in Ara-C-treated  retinas  (19,  29)  did not resolve 
the question of whether the increases in GS levels 
were  due to an  accelerated  rate  of synthesis or a 
decreased rate of degradation of the enzyme. This 
and  related  questions  bearing  on  the  Ara-C-me- 
diated changes in retinal GS levels were examined 
in  the  present  study  by  radioimmunochemical 
measurements:  rates  of GS synthesis  were moni- 
tored  by  precipitating  radioactively  labeled  GS 
from retina sonicates, using a highly specific prep- 
aration  of  v-globulin  isolated  from  antiserum 
against  purified  retinal  GS,  the  most  sensitive 
method currently available for analysis of enzyme 
synthesis in this system. Comparison of the results 
obtained in this investigation with immunochemi- 
cal data on GS induction by hydrocortisone dem- 
onstrates  that  the two effectors elicit increases in 
GS levels by different mechanisms. 
MATERIALS  AND  METHODS 
Tissue  Culture 
Neural  retina  tissue  was  aseptically  isolated  from 
white  Leghorn  chicks  on  the  10th  day  of embryonic 
development (14, 29). Each retina was cultured at 37~ 
in a  25-ml Erlenmeyer flask  containing 3 ml of culture 
medium (Tyrode's balanced salt solution with 20% fetal 
bovine serum [FBS] and 50 U/ml each of penicillin  and 
streptomycin). The medium was  gassed with 5% CO2- 
95% air mixture and the flasks were rotated 70 rpm, as 
previously described  (15,  30).  All culture  media were 
supplemented with the same preparation of FBS (lot no. 
2071382,  tissue culture select grade, BioQuest, BBL & 
Jones, R. E. Manuscript in preparation. 
Falcon  Products,  Becton,  Dickinson  &  Co.,  Cockeys- 
ville, Md.) which was prescreened to ensure the absence 
of effectors which increase retinal GS activity (14). 
Increases in the level of GS were elicited by adding 
Ara-C hydrochloride (lot no. 3129W, Upjohn Co., Ka- 
lamazoo, Mich.) to the culture medium at the beginning 
of incubation to a final concentration of 7.5 raM. Steroi- 
dal induction of GS was achieved by adding hydrocorti- 
sone  (free  alcohol)  to  the  culture  medium  to  a  final 
concentration of 0.92  /zM, as previously described (29, 
30).  Actinomycin D  (Act  D)  (Merck  Chemical Div., 
Merck & Co., Inc., Rahway, N. J.) was added to retina 
cultures to a final concentration of 10/zg/ml, as indicated 
in the text. This dose of the antibiotic inhibits 98-99% of 
[aH]uridine  incorporation in the retina without inactivat- 
ing GS or blocking the translation required for GS accu- 
mulation  (26,  29,  30).  Whenever  retinas  were  trans- 
ferred  to  fresh  culture  medium,  they were  washed  in 
three changes of final medium in flasks  rotated at  100 
rpm, as described before (15). At the end of the incuba- 
tion  period,  the  retinas  were  rinsed  in  cold Tyrode's 
solution  and  prepared  for  enzyme  assay,  scintillation 
counting, or immunological determinations, as described 
below. 
Physicochemical Analyses of Ara- C 
The  preparation  of  Ara-C  used  in  this  study  and 
several other lots of the nucleoside obtained from differ- 
ent commercial suppliers  have been extensively screened 
by the following methods: ultraviolet and infrared spec- 
troscopy;  recrystallizations  from  solution;  organic  sol- 
vent extractions; Sephadex column chromatography; pa- 
per,  thin-layer,  and  gas-liquid  chromatography.  These 
tests  1 revealed no detectable steroidal contaminants  in 
any preparation of Ara-C used in our studies. 
Enzyme Assay 
Retinas were suspended in 10 mM phosphate buffer, 
pH  7.1,  and  disrupted  at  0~  with  six  1-s  bursts  of 
ultrasound from a Biosonik III model B10-111  sonifier 
(Will Scientific,  Inc., Rochester, N. Y.) tuned to maxi- 
mum output.  Aliquots of tissue  sonieates were assayed 
for GS activity by the glutamyltransferase reaction (19); 
replicate aliquots were assayed for protein by the method 
of Lowry et al. (24), using bovine serum albumin as the 
standard.  GS specific  activity was  expressed  as micro- 
moles  of 7-giutamylhydroxamate  (GHA)  formed  per 
hour  per milligram of tissue  protein.  The  presence of 
Ara-C, HC, or Act D  in the enzyme assay  mixture did 
not interfere with measurements of GS activity. 
Radioisotopic Labeling 
Retina proteins were labeled by adding 14C-L-amino 
acid mixture (NEC-445, 10 mCi/mmol each; New Eng- 
land Nuclear, Boston, Mass.)  or all-L-amino acid mix- 
ture  (NET-250;  New England  Nuclear) to the culture 
medium. The quantity of isotope and duration of expo- 
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legends. Measurements of isotope incorporation into ret- 
ina  proteins,  amino  acid  uptake,  and  procedures  for 
liquid scintillation counting were as previously described 
(15, 29). The radioactivity of each sample was expressed 
as disintegrations per minute per milligram of protein. 
Gamma Globulins 
Normal  (preimmune)  rabbit  serum  and  antiserum 
against highly purified chick retina glutamine synthetase 
were obtained as described before (33, 36). ),-Globulin 
was isolated by ammonium sulfate precipitation, accord- 
ing to the procedure of Stelos (41). The reactions of GS 
with  normal and  anti-GS ),-globulins were  studied  by 
quantitative immunoprecipitin tests (see legend, Fig. 1), 
polyacrylamide gel electrophoresis, and immunoelectro- 
phoresis. 
Immunoelectrophoresis 
The  immunological specificity of anti-GS ),-globulin 
was  monitored  by  immunoelectrophoresis  using  glass 
slides coated with 1%  agarose  (Bio-Rad Laboratories, 
Richmond, Calif.) in 0.025  M  barbital buffer, pH  8.2. 
Two antigen solutions were tested: (a) 105,000-g super- 
nates  of  retina  sonicates  (25  mg  of  lyophilized  adult 
retina tissue in  1 ml of  10 mM phosphate buffer, pH 
7.1), and (b) highly purified chick retina glutamine syn- 
thetase  prepared  as  described  by  Sarkar  et  al.  (36). 
Approx.  15  /.d of each  antigen  (2250  p,g of protein) 
were electrophoresed for 1 h in barbital buffer using an 
LKB  model  3276-50  electrophoresis  apparatus  (LKB 
Instruments, Inc., Rockville, Md.); average voltage and 
current were  325  V  and 6  mA, respectively. Antigens 
were then reacted with 175-200/~1 of anti-GS ),-globulin 
(upper troughs), and with the same amount of normal ),- 
globulin  (lower troughs).  The  slides were  placed  in  a 
humidified chamber for 30 h at 4~  for development of 
precipitin arcs, then washed for 48 h  at 4~  in several 
changes of 2%  NaC1,  rinsed with distilled water,  and 
dried for 5 h at 37~  The slides were stained for 5 min 
with 2% amido black 10 (Chroma-Gesellschaft, Schmid 
and Co.,  Stuttgart-untertiirkheim, Germany) in glacial 
acetic acid-methanol-water (1:2:2), destained with 2% 
acetic acid, and dried. Replicate immunoelectrophoreto- 
grams were obtained using serially diluted preparations 
of antigen and ),-globulin. 
Radioimmunoassay 
The radioimmunoassay for measuring newly synthe- 
sized GS in the retina was modified from that previously 
described  (1,  2,  30).  Cultures  of  10-day  embryonic 
neural retina were supplied with all- or ~4C-amino acid 
mixture;  labeling conditions are  noted in the text and 
legends. At the end of the labeling period, the retinas 
were thoroughly washed with cold Tyrode's solution and 
sonicated in 10 mM phosphate-0.85% NaC1 buffer, pH 
7.1 (PBS). 105,000-g supernates of retina sonicates were 
prepared  and  aliquoted  for  reaction  with ),-globulins. 
Unlabeled carrier GS from adult chick retina was added 
to each aliquot to bring the total enzyme activity units to 
a uniform level (2.5 GHA) optimal for maximal precipi- 
tation of the enzyme.  GS was precipitated from these 
samples with  20  /~1 of anti-GS ),-globulin; nonspecific 
precipitation of radioactivity was monitored by reacting 
replicate aliquots with ),-globulin isolated from normal 
rabbit serum (see below). The following additional com- 
ponents were included in the precipitation mixture: 500 
/zg of bovine serum albumin, 500/zg of sodium deoxy- 
cholate, 20/~1 of 2.5% Triton X-100; PBS was added to 
bring the final volume to  1.0 ml. Immunoprecipitation 
reactions were performed in sterile plastic test tubes to 
avoid the  adherence of labeled proteins to  glass.  The 
precipitation mixtures were incubated for 30 min at 37~ 
and 12-16 h at 4~  The immunoprecipitates were col- 
lected by centrifugation, washed three times with PBS 
containing 0.05% sodium deoxycholate and 0.05% Tri- 
ton X-100, and processed for liquid scintillation count- 
ing,  as  described before  (15).  The  disintegrations per 
minute per milligram of protein precipitated with normal 
),-globulin were  subtracted from that precipitated with 
anti-GS ),-globulin  to  obtain  the  radioactivity  due  to 
specific precipitation of isotopically labeled GS. 
Controls for Nonspecific Radioactivity 
in lmmunoprecipitates 
In addition to using normal ),-globulin as a control for 
nonspecific radioactivity in antigen-antibody complexes 
(see above), we have monitored nonspecific radioactivity 
by another widely used procedure (16,  17, 21, 32, 43, 
44),  originally described  by  Schimke  et  al.  (39).  For 
these tests, retinas were cultured either in medium con- 
taining 7.5  mM Ara-C or in control medium (without 
Ara-C). 3H-L-amino  acid mixture was added to all cul- 
tures at the beginning of incubation to a final concentra- 
tion of 16.7  /zCi/ml. After 24 h, the retinas were har- 
vested  and  aliquots of  105,000-g  supernates  were  re- 
acted  with anti-GS or normal 3,-globulin,  as described 
above. The supernates remaining after removal of mate- 
rials precipitated by anti-GS )'-globulin were subjected to 
a second precipitation by again adding unlabeled carrier 
GS and anti-GS )'-globulin in antigen-antibody equiva- 
lence; the second precipitates were processed identically 
to the first. The radioactivity in the second precipitate 
was subtracted from the radioactivity in the first to calcu- 
late the quantity of labeled GS specifically  precipitated 
by anti-GS )'-globulin. 
Table I (column 6) shows that the average percent of 
total radioactivity precipitated by normal T-globulin var- 
ied  between  0.14  and  0.21%  for control and  Ara-C- 
treated retinas, respectively. Anti-GS )'-globulin precipi- 
tated only about 0.05% of the total radioactivity remain- 
ing after the first immunoprecipitation with anti-GS ),- 
globulin, regardless of the source of antigen. The facts 
that  the  values obtained with normal ),-globulin were 
significantly greater than the corresponding values ob- 
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Comparison  of Procedures for Determination of GS-Specific Radioactivity in Immunoprecipitates* 
Net GS radio- 
Radioactiv- Total  radio-  activity  ex- 
ity predpi-  activity  pre-  pressed as % 
Total add-in-  tated by  cipitated  by  of total acid- 
soluble radio-  Retina  pro-  gamma  gamma  Net GS ra-  insoluble  ra- 




dpmlmg Protein  mg  dpm/mg Pro-  %  dpm/mg  Pro- 
x 104  rein ￿  tO  -~  tein ￿  10 "~ 
6.08  0.64  Anti-GS  7.19  1.18  5.91~  0.97 
Normal  1.28  0.21 
7.03  0.75  Anti-GS  2.20  0.31  1.21:~  0.17 
Normal  0.99  0.14 
Second Immunoprecipitation 
Ara-C  6.01  0.63  Anti-GS  0.30  0.05  6.89w  1.15 
Control  7.01  0.75  Anti-GS  0.40  0.06  1.80w  0.26 
* Values shown are averages of triplicate determinations. 
:[: Radioactivity precipitated by anti-GS y-globulin minus radioactivity precipitated by normal y-globulin. 
w Radioactivity precipitated by anti-GS y-globulin during first immunoprecipitation minus radioactivity precipitated 
by anti-GS y-globulin during second immunoprecipitation. 
tained with the second immunoprecipitation procedure, 
and  that  they  showed  differences  dependent  upon 
whether or not the tissue was treated with Ara-C, suggest 
that  the  normal y-globulin controls detect the entrap- 
ment, co-precipitation, or denaturation  of labeled non- 
GS proteins; moreover, the generation of this nonspe- 
cific radioactivity is apparently restricted primarily to the 
incubation period of the first immunoprecipitation. Un- 
der such  conditions, these labeled nonspecific proteins 
would be removed during the first immunoprecipitation 
with anti-GS y-globulin and their contribution could not 
be detected by performing a  second  immunoprecipita- 
tion. Accordingly, we have corrected all immunoassay 
data in this  report for nonspecific radioactivity by sub- 
tracting the radioactivity precipitated by normal y-globu- 
lin from that precipitated by anti-GS y-globulin, rather 
than employing the second immunoprecipitation proce- 
dure. 
Polyacrylamide  Gel  Electrophoresis 
Radioactively  labeled  immunoprecipitates  (see  leg- 
end,  Fig. 2) were subjected to electrophoresis on gels 
containing 5%  acrylamide, 0.19%  N,N'-methylenebis- 
acrylamide, and 0.2% sodium dodecyl sulfate (SDS), as 
described  (8,  40).  Immunoprecipitates  were  prepared 
for electrophoresis by incubating each sample at 37~  for 
15 min with 200 tzl of electrophoresis buffer and 50 tzl of 
the following mixture: 5% SDS, 50 mM Tris.HC1 (pH 
8.0),  5  mM EDTA,  200  mM dithiothreitol,  50%  su- 
crose, and 50 tzg/ml of pyronin Y  (8).  Electrophoresis 
was performed at 8.5 mA/gel and terminated when the 
tracking dye had migrated 85 mm from the origin. The 
gels were cut into 1.5-mm slices and placed in scintilla- 
tion  counting  vials  (two  slices  per  vial).  Radioactive 
materials were eluted by incubating the slices for 4 h at 
50~  with  1 ml of NCS (Amersham/Searle Corp., Ar- 
lington  Heights,  111.); toluene-based  fluors  and  laaBa 
external standardization were utilized for liquid scintilla- 
tion counting, as described before (15). 
GS from chicken  retina  was  obtained  as previously 
described (36);  10/zg of enzyme was treated with SDS, 
as described above, electrophoresed as marker, and lo- 
calized by staining  with Coomassie Blue R-250. 
RESULTS 
Specificity  of Anti-GS  ~/-Globulin 
A  typical  quantitative  immunoprecipitin  reac- 
tion between anti-GS '/-globulin and GS is shown 
in Fig.  1.  In this test,  anti-GS '/-globulin precipi- 
tated up to three enzyme activity units at an effi- 
ciency >92%; '/-globulin from normal serum pre- 
cipitated < 1% of the input GS activity units. When 
a  crude  extract  of total  retina  proteins  was  sub- 
jected  to  immunoelectrophoresis,  only  a  single 
precipitin  arc  was  obtained  upon  reaction  with 
anti-GS 3,-globulin (Fig.  1, inset A). An identical 
arc  was  obtained  when  highly  purified  GS  was 
used  as  the  antigen  (Fig.  1,  inset  B).  Serially 
diluted  preparations  of  antigen  or  ,/-globulin 
yielded  identical  immunoelectrophoretograms. 
There  were  no detectable  arcs  when  the electro- 
phoresed  antigens  were  reacted  with  normal  ,/- 
globulin. 
R.  E.  JONES AND  A.  A.  MOSCONA  Ara-C and Glutamine Synthetase.  H  33 FIGURE 1  Reactions between GS and anti-GS y-globulin. Lyophilized adult retina tissue was sonified in 
10 mM PO4-0.85% NaCl buffer, pH 7.1 (PBS), and 105,000-g supernates were diluted with PBS to a 
final concentration of 10 GS enzyme activity units (GHA) per ml. Aliquots of this mixture containing in- 
creasing quantities of  GHA were precipitated  with 20  ~l of anti-GS T-globulin (see Materials and 
Methods). Immunoprecipitates were collected by centrifugation and the supernates were assayed for GS 
activity. A quantitative immunoprecipitin curve was obtained by comparing the GHA added to the reac- 
tion mixture with the  GHA remaining in the supernate  after immunoprecipitation. Inset: Immunoe- 
lectrophoretograms (for details, see Materials and Methods). Upper troughs, anti-GS T-globulin; lower 
troughs, normal ~-globulin. Antigen(s) in center well: (A) total retina proteins (105,000-g supernates); 
(B) highly purified GS from chicken retina. 
Fig.  2  shows the results of polyacrylamide gel 
electrophoresis of immunoprecipitates formed by 
the reaction of anti-GS or normal 3,-globulin with 
radioactively labeled  proteins  from  control  and 
Ara-C-treated  retinas.  The  immunoprecipitates 
obtained with anti-GS ~/-globulin  contained only 
one predominant peak of radioactivity which elec- 
trophoresed  precisely to  the  location of the  GS 
subunit marker. Conversely, there was no signifi- 
cant  radioactivity  detectable  in  the  GS  region 
when precipitates formed with normal y-globulin 
were subjected to electrophoresis. Background ra- 
dioactivity across the gel (presumably due to non- 
specific  entrapment of labeled materials) was vir- 
tually identical in imrnunoprecipitates formed by 
either  anti-GS or  normal y-globulin. Thus,  the 
above  tests  indicate that  (a)  anti-GS y-globulin 
selectively precipitates this enzyme from a mixture 
of total retina proteins, and (b) the low levels of 
nonspecific  radioactivity  in  immunoprecipitates 
obtained  with  anti-GS -y-globulin can  be  moni- 
tored reliably by determining  the radioactivity pre- 
cipitated by normal 3,-globulin. 
Accumulation of GS in Embryonic 
Neural Retinas  Treated 
with Ara-C 
When  neural retina tissue  from  10-day chick 
embryos is cultured for 24 h in medium containing 
7.5 mM Ara-C, GS specific activity increases sev- 
eral-fold (Fig. 3). Previous work has shown that 
the kinetics of GS accumulation closely resemble 
those obtained with the steroid inducer hydrocor- 
tisone  and that  RNA  and protein synthesis are 
required for the increase in GS activity mediated 
by the nucleoside (15). As shown in Fig. 3 [+(Act 
D)0h], addition to the cultures of 10/zg/ml Act D 
together with Ara-C prevented the increase of GS. 
However, if Act D  was added after 5-h exposure 
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FIGUR~  2  Polyacrylamide gel electrophoresis of immu- 
noprecipitates. Retinas were cultured either in medium 
containing 7.5 mM Ara-C or in medium lacking Ara-C 
(controls).  all-L-amino acid  mixture  was  added  to  all 
cultures at the beginning of incubation to a final concen- 
tration of 16.7 p,  Ci/ml. After 24 h of labeling, the retinas 
were harvested,  sonicated  in  PBS,  and  centrifuged at 
105,000-g for 30 min. Aliquots of the supernates (each 
containing  1.91  mg  protein)  were  precipitated  with 
either anti-GS T-globulin or normal T-globulin, using the 
radioimmunoassay  protocol  given  in  Materials  and 
Methods.  The  immunoprecipitates were  washed  three 
times with PBS containing 0.05% sodium deoxycholate 
and 0.05% Triton X-100, treated with SDS, and electro- 
phoresed on 5% polyacrylamide gels (see Materials and 
Methods). Data above show the distribution of radioac- 
tivity obtained when 760/zg of each solubilized immuno- 
precipitate was subjected to electrophoresis. Horizontal 
bar indicates position of GS subunits  run in parallel gels 
as marker (molecular mass  -42,000  daltons). 
to  Ara-C,  GS  activity  continued  to  accumulate 
throughout  the 24-h culture period to levels close 
to those obtained with Ara-C alone [+(Act D)5 h]" 
Furthermore,  when  retinas  were cultured for 5  h 
in  medium  with Ara-C,  then  thoroughly  washed 
and transferred  into medium containing only Act 
D,  GS  activity increased  to  levels that  often  ex- 
ceeded those reached in the continuous  presence 
of the  nucleoside  [W(Act  D)5 h].  NO measurable 
increase  in  GS  activity was  elicited when  Act  D 
was  added  to  retinas  cultured  in  the  absence  of 
Ara-C, regardless of the time of administration of 
the  antibotic.  Previous findings  have  shown  that 
cycloheximide prevents the increase in GS activity 
which occurs during  Act D  treatment  (15),  indi- 
cating that this transcription-independent  increase 
in enzyme activity requires protein synthesis. The 
following  immunochemical  experiment  demon- 
strated that the increase in GS activity during Act 
D  treatment  represents  accumulation  of  newly 
synthesized GS. 
Retinas were cultured in either the presence or 
absence of 7.5 mM Ara-C and were labeled with 
1.0  /zCi/ml 14C-amino  acid mixture from the be- 
ginning of incubation.  After 5  h,  Act D  (10  /zg/ 
ml)  was  added  to  half of the  Ara-C-treated  cul- 
tures;  the remainder  was  incubated  continuously 
with the nucleoside. After varying periods of incu- 
bation, GS specific activities were determined and 
the  quantity  of 14C-labeled  GS was  measured  by 
immunoassay.  The results (Table II) showed that 
increases of enzymatic activity coincided with the 
accumulation  of ~4C-labeled  GS,  whether  or not 
Act D  was added  after the  5th  h  of culture  with 
Ara-C. There  was only slight accumulation  of la- 
beled GS in control cultures, which corresponded 
to the basal increase in GS specific activity typical 
of retinas cultured in medium without added effec- 
tors (see also Table I  and Fig.  2). 
The above results have indicated that  (a) RNA 
synthesis is required during  the first 5  h  of treat- 
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FIGURE 3  Effects of Act D on GS accumulation  in Ara- 
C-treated retinas. Retinas were cultured in medium con- 
taining  either Ara-C (7.5  mM)  or no  additions  (con- 
trois). The tissues  were treated with Act D  (10 /zg/mi) 
and GS specific  activities  were compared after 24 h of 
incubation under the following conditions:  +(Act D)oh, 
Act D added at 0 h with or without Ara-C; +(Act D)sh, 
Act D  added  after the 5th h  of incubation  to cultures 
with  Ara-C;  W(Act  D)sh,  retinas  cultured  for  5  h  in 
medium with  Ara-C, then washed and transferred into 
medium containing only Act D. Points shown are aver- 
ages of four determinations; vertical lines indicate range 
of values obtained in five different experiments. 
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Accumulation of ~4C-Labeled GS in Embryon& Retinas Treated with Act D after Exposure to Ara-C 
Incorporation of t4C- 
amino acids into total  Immunopredpitated 
Treatment  retina proteins  Retina protein reacted  t4C-labeled  GS  GS sp act 
dpm/mg Protein  x  lO-*  mg  Net  dpm/mg  protein !  GHA/mg Protein 
x  10  ~ 
2.56  2.10  0.41  0.40* 
1.92  2.23  0.76  0.74 
Control, 5 h 
Ara-C,  5 h 
Control,  8 h  4.00  1.85  0.52  0.45 
Ara-C, 8 h  2.96  1.78  1.58  1.40 
Ara-C, 0-8 h; Act D, 5-8 h  2.42  1.92  1.25  1.30 
Control, 24 h  5.23  0.72  0.70  0.61 
Ara-C,  24 h  3.92  0.66  3.53  3.80 
Ara-C, 0-24 h; Act D, 5-24 h  2.67  0.79  3.42  3.18 
Retinas were cultured in medium containing 7.5 mM Ara-C; controls were cultured in nucleoside-free medium. 1.0 
/zCi/m114C-amino acid mixture was added to all cultures at the beginning of incubation. Act D (10/xg/ml) was added 
after 5-h exposure to Ara-C, as indicated above. Retinas were collected after 5,8, and 24 h and 105,000-g supernates 
were prepared;  duplicate aliquots were assayed for incorporation of 14C-amino acids into total retina proteins,  GS 
specific activity, and for 14C-labeled GS, as described in Materials and Methods. 
* GS specific activity of freshly isolated neural retina was 0.30. 
of GS activity, and to allow the subsequent accu- 
mulation of GS to become independent of further 
transcription;  (b)  the  RNA templates  which  ac- 
crue during the 0-5-h exposure to Ara-C can me- 
diate GS accumulation when further transcription 
is  arrested  with  Act  D;  (c)  the  increase  in  GS 
levels in retinas treated with Ara-C alone, or with 
Act  D  after  5-h  exposure  to  Ara-C,  is  due  to 
accumulation of GS molecules which are  synthe- 
sized de novo. 
Previous work on the induction of GS by HC has 
shown that the steroid elicits accumulation of ac- 
tive GS-specific RNA templates in the embryonic 
retina (29) which results in a several-fold increase 
in  the  rate  of  GS  synthesis  (30).  Thus,  it  was 
imperative  to  determine  whether  the  accumula- 
tion  of GS  elicited by  Ara-C also  resulted  from 
increases  in  the  rate  of  GS  synthesis.  This  was 
examined by  comparing directly the  rates  of GS 
synthesis in retinas cutured with Ara-C or HC. 
Comparison  of the Rates of GS 
Synthesis in  Retinas  Treated 
with Ara-C or HC 
Retinas  were  cultured  in  medium  containing 
either 7.5  mM  Ara-C or 0.92  /zM HC; controls 
did not have these additions. After various periods 
of incubation, the cultures were pulse-labeled for 
15  min with 3.3  p.Ci/ml 14C-amino  acid mixture. 
The brief exposure  to radioisotope excluded en- 
zyme turnover as a major factor in interpretation 
of these  results  (17,  30).  The retinas were  soni- 
cated  and  105,000-g  supernates  were  prepared 
(see Materials and  Methods).  GS was selectively 
precipitated from the mixture of radioactively la- 
beled proteins by addition of anti-GS ~/-globulin; 
the  specificity and  precipitation efficiency of this 
reaction were identical to those shown in  Figs.  1 
and 2. Nonspecific immunoprecipitation was mon- 
itored by treating duplicate  samples with normal 
~/-globulin;  though slight, the radioactivity precipi- 
tated by normal ?/-globulin was always subtracted 
from that precipitated by anti-GS 7-globulin. The 
corrected  immunoprecipitated  radioactivity  pro- 
vided  a  direct  measurement  of  the  rate  of  GS 
synthesis. 
The results (Table II  0  showed that  Ara-C did 
not elicit an  increase in  the  rate  of GS synthesis 
over the basal level. Increases in enzyme accumu- 
lation resulting from de novo enzyme synthesis can 
only be  due  to  either an  increase  in  the  rate  of 
synthesis or a decrease in the rate of degradation 
of the enzyme. In the case of Ara-C-treated reti- 
nas,  GS accumulates even though the rate of en- 
zyme  synthesis  remains  identical  to  that  of  un- 
treated controls; this strongly suggests that Ara-C 
mediates GS accumulation by preventing the turn- 
over of GS which normally limits enzyme accumu- 
lation in  the uninduced retina. 
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Rates of GS Synthesis  in Am-C- and HC-Treated Retinas 
Hours in culture 
Rate of synthesis 
Treatment  Retina protein  reacted  Total protein  GS  GS sp act 
mg  dpm/mg Protein  Net dpm/mg protein  GHA/mg protein 
x  I0 -4 
Control  2.07  7.50  73  0.36 
Ara-C  2.24  2.90  69  0.39 
HC  2.11  7.61  110  0.59 
Control  1.84  8.16  80  0.42 
Ara-C  1.79  2.26  75  0.80 
HC  1.65  8.32  450  1.38 
Control  1.88  8.68  72  0.44 
Ara-C  1.91  2.46  79*  1.26 
HC  1.55  8.60  590  1.77 
Retinas were cultured in medium containing either 7.5 mM Ara-C or 0.92/zM HC; control cultures were without 
these additions. The cultures were pulse-labeled for 15 min with 3.3 /zCi/ml ~4C-amino  acid mixture immediately 
before collection at the times shown above. The retinas were washed, sonieated, and 105,000-g supernates were 
prepared.  Rates  of total  protein synthesis were monitored by determining the total quantity of TCA-insoluble 
radioactivity  in the retina; rates of GS synthesis were determined by radioimmunoassay and corrected for nonspecific 
radioactivity, as described in Materials and Methods. Replicate aliquots of each 105,000-g supernate were assayed 
for GS specific activity. 
* The rate of GS synthesis in Ara-C-treated retinas remained in the basal range between the 8th and 24th hours of 
culture. 
In accord  with previous findings (30),  the  in- 
crease of GS activity in retinas induced by hydro- 
cortisone was due to  acceleration of the  rate  of 
enzyme synthesis (Table III). Thus, considering 
the  effects on rates of GS synthesis, the  mecha- 
nism by which Ara-C increases GS levels in the 
embryonic retina is distinctly different from that of 
HC. 
The  rate  of total  protein  synthesis in  HC-in- 
duced retinas never deviated more than 2% from 
controls (Table III); thus, the increase in the rate 
of GS synthesis represents a selective response to 
the steroid inducer, as noted previously (30). Nei- 
ther Ara-C nor HC measurably altered the uptake 
of 14C-amino acids into the acid-soluble fraction of 
the retina. In contrast to HC, the effective concen- 
tration of Ara-C (7.5 mM) inhibited the incorpo- 
ration of ~4C-amino acids into total retina proteins 
60-70%  (Table III). Yet, this massive inhibition 
neither prevented de novo synthesis of  GS  nor 
measurably reduced the rate of GS synthesis be- 
low control levels; this indicates that the suppres- 
sion of retinal protein synthesis by Ara-C is highly 
differential. 
The above findings have led to two seemingly 
incongruent conclusions: first,  the  evidence sug- 
gests  that active templates for GS synthesis accu- 
mulate  in  Ara-C-treated  retinas but  not  in  un- 
treated controls (Fig. 3); second, while the rate of 
GS synthesis in Ara-C-treated retina is not higher 
than in controls, GS accumulates to levels consid- 
erably above those  of controls (Table III). The 
following experiments were undertaken as a first 
step toward resolution of this apparent paradox. 
Effects of Ara-C on the Expression of 
Preformed Templates for 
GS Synthesis 
Retinas were  cultured in the  presence  of  7.5 
mM Ara-C. After 5 h, the cultures were divided 
into two  groups:  the  first  group  was  washed  to 
remove Ara-C; the second group was not. Act D 
(10/~g/ml) was then added to both sets of cultures 
in order to stop further transcription; therefore, 
the subsequent synthesis of GS was restricted to 
that  mediated  by templates which  had  accumu- 
lated during the initial 0-5-h culture period. After 
varying periods of treatment with Act D, the reti- 
nas were labeled for 15 min with 3.3 p.Ci/ml 14C- 
amino  acid  mixture  and  then  immediately har- 
vested. Rates of GS synthesis were determined by 
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FIGURE 4  Rates of GS synthesis  in embryonic retinas 
treated  with  Act  D  after  exposure  to  Ara-C.  Neural 
retina tissue from 10-day chick embryos was cultured in 
medium containing 7.5 mM Ara-C (shaded bars); con- 
trol cultures were without Ara-C (white bars). After the 
5th  h  of incubation,  experimental  and  control  tissues 
were  simultaneously  treated  with  Act  D  (10  p.g/ml) 
according to one of two procedures:  (A) retinas thor- 
oughly  washed  to  remove Ara-C,  then  transferred  to 
fresh medium containing only Act D; (B) Act D added 
directly to retina cultures without removal of Ara-C. For 
each case, the retinas were labeled for 15 min with 3.3 
/zCi/ml 14C-amino acid mixture immediately before col- 
lection after 0.5,  1.5, and 3.0 h of exposure to Act D. 
The  tissues  were  subjected  to  radioimmunoassay  for 
determination of the rate of GS synthesis,  as described in 
Materials and Methods. Values shown are the average of 
four independent determinations; vertical lines indicate 
range of values obtained in two separate experiments. 
immunoprecipitation  of the  radioactively labeled 
enzyme, as described above. The following condi- 
tions were compared: (a) absence of Ara-C during 
treatment with Act D, and (b) presence of Ara-C 
during  Act  D  treatment. 2 Controls  consisted  of 
Previous findings  suggested that increases in GS activ- 
ity elicited by Ara-C may be associated with the inhibi- 
tion of regulatory gene transcription; withdrawal of Ara- 
C restores RNA synthesis and presumably the activity of 
the regulatory genes, resulting in cessation of GS accu- 
mulation (15). Addition of Act D at the time of Ara-C 
withdrawal  prevents  restoration  of transcription  while 
permitting continued synthesis of GS [see Fig. 3, W(Act 
D)5 h]. Accordingly, to most easily evaluate the effects of 
Ara-C on translation of preformed GS templates, Act D 
was used in these experiments to prevent possible  reini- 
tiation  of regulatory gene  activity  upon  withdrawal  of 
Ara-C. 
retinas  that  were  not  exposed  to  Ara-C;  either 
they  were  washed  after  5  h  and  transferred  to 
fresh medium with Act D  or Act D  was added to 
the culture medium at  5  h. 
As shown  in  Fig.  4 A, when  Ara-C  was  with- 
drawn with simultaneous addition of Act D  at 5 h, 
there was a prompt 4.2-fold increase in the rate of 
GS  synthesis  relative  to  controls;  this  increase 
persisted for at least 3 h, though its absolute level 
declined  somewhat  with  time.  When  Ara-C  was 
not withdrawn  at the time of Act D  addition, the 
rate of GS synthesis did not increase above control 
levels  (Fig.  4B).  Thus,  marked  differences  can 
exist between the rates of GS synthesis in Ara-C- 
treated  retinas,  depending  upon  whether the nu- 
cleoside is present  or absent  during  Act D  treat- 
ment. 
The results of these immunochemical measure- 
ments  (Fig.  4A)  further  support  the  suggestion 
that  exposure  of  the  retina  to  7.5  mM  Ara-C 
causes  an  accumulation  of templates for GS syn- 
thesis; they show that these templates can mediate 
a  sustained  increase  in  the  rate  of GS  synthesis 
after the nucleoside is removed and further tran- 
scription is halted with Act D. Acceleration of the 
rate  of  GS  synthesis  was  not  an  indiscriminate 
cellular response evoked by Act D: Act D  did not 
elicit an increase in the rate of GS synthesis either 
in  control  cultures  (Fig,  4)  or  in  the  continued 
presence of Ara-C (Fig. 4 B). 
By  comparing  the  results  shown  in  Table  II, 
Table III, and  Fig. 4,  it can  be deduced  that  the 
effects of Ara-C on retinal GS levels are not attrib- 
utable to major alterations in the specific activity 
of amino acid pools or of amino-acyl tRNA.  For 
example, if the accumulation of 14C-labeled GS in 
Ara-C-treated  retinas  (Table  II)  was  due  to  in- 
creases in the specific activity of either the amino 
acid  pools  or  the  amino-acyl  tRNA,  one  would 
expect to find a concomitant increase in the incor- 
poration  of laC-amino acids into total retina pro- 
teins,  rather  than  the  reduction  observed  under 
these  conditions  (Tables  II and  III).  Conversely, 
the possibility that the low rates of synthesis of GS 
and total protein  in Ara-C-treated  retinas  (Table 
III) may be associated with either an inhibition in 
the charging of tRNA or a reduction in the specific 
activity of amino acid pools is inconsistent with the 
finding  that  accumulation  of  ~4C-labeled  GS  in- 
creases  -400%  during  the  24-h  culture  period 
(Table II).  Measurements  of total uptake  and in- 
corporation  of ~4C-amino acids by the retina also 
provided  indirect  evidence  that  the  fourfold  in- 
crease in the rate  of GS synthesis  occurring with 
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simply reflect an equivalent increase in the specific 
activity of the  amino acid pool. First, uptake of 
labeled amino acids into the acid-soluble fraction 
of the retina did not increase upon withdrawal of 
Ara-C  and  transfer  to  fresh  medium  containing 
Act D. Second, this treatment caused only a 20% 
increase in 14C-amino  acid incorporation into total 
retina proteins; the increase was detectable during 
only the first  30  min  of exposure to  Act D  and 
occurred in both control and Ara-C-treated reti- 
nas. This increase in total protein synthesis is not 
sufficient to account  for the  >400%  increase in 
the rate of GS synthesis which occurs in  Ara-C- 
treated retinas under these conditions (Fig. 4 A). 
Presently, the  most  plausible interpretation of 
the  above results is that  Ara-C limits or hinders 
some translational process(es) necessary for maxi- 
mal expression of messenger RNA for GS. Thus, 
in retinas cultured continuously with  Ara-C, the 
rate  of GS synthesis does not  increase over the 
basal level (Table III), despite the accumulation of 
potentially  translatable  GS  templates  (Fig.  3); 
withdrawal  of  Ara-C  removes  this  translational 
hindrance and permits expression of the accumu- 
lated templates, resulting in a  greater than  basal 
rate of GS synthesis (Fig. 4 A). 
DISCUSSION 
Comparison  of the Mechanism o fAction 
of Ara-C and HC 
HC,  an  l l-fl-hydroxycorticosteroid, and  Ara- 
C,  a  synthetic  nucleoside,  independently  cause 
significant increases in GS levels in the embryonic 
neural retina. The increase of GS elicited by Ara- 
C  is  not  causally related  to  inhibition  of DNA 
synthesis by the  nucleoside; however,  there  is a 
direct correlation between the selective inhibition 
of RNA synthesis by Ara-C and the concomitant 
increase in retinal GS (15).  Both Ara-C and HC 
bring  about  accumulation  of  RNA  templates 
which mediate de novo synthesis of the enzyme (1, 
15, 29); however, the rate of expression of these 
templates is different with each effector. The pres- 
ent study demonstrates that  the  increases in the 
level of GS elicited by Ara-C and HC are achieved 
through  different  mechanisms;  these  differences 
apply to control processes governing the accumu- 
lation of RNA templates for GS synthesis, the rate 
of GS synthesis, and the rate of GS turnover. 
PROVISION  AND  EXPRESSION  OF  GS-SPE- 
CIFIC  TEMPLATE  RNA"  The  initial  events  in 
the induction of GS by HC  are similar to those 
known from other cases of steroid-cell interactions 
(4, 9,  12,  13, 31).  HC binds to specific cytoplas- 
mic receptors in the retina (6, 20), and the steroid- 
receptor complexes ultimately bind to sites within 
the nucleus (34, 35).  Shortly thereafter, GS-spe- 
cific template RNA begins to accumulate and the 
rate  of enzyme  synthesis in  the  retina  increases 
(25,  29),  but there are no gross changes in total 
RNA or protein synthesis (25, 26). According to a 
hypothesis  advanced  earlier  (26,  30),  HC  may 
elicit accumulation of active templates for GS syn- 
thesis by causing a  reduction of repressor mole- 
cules  which  prevent  the  accumulation  of  these 
templates in the uninduced retina. 
It is unlikely that  the effects of Ara-C involve 
complexing of the nucleoside with HC-specific cy- 
toplasmic  receptors;  furthermore,  reactions  of 
Ara-C with the genome must be assumed to differ 
from those of HC. This is emphasized by the fact 
that  the  concentrations of Ara-C which increase 
GS levels also cause a  very marked inhibition of 
macromolecular synthesis in the retina (15); it is 
possible  that  this  results  in  a  reduction  of  the 
postulated repressor which, in turn, results in ac- 
cumulation  of templates  for  GS  synthesis.  This 
assumption presupposes a differential inhibition of 
RNA synthesis in the retina by the effective con- 
centrations  of  Ara-C  and,  in  fact,  it  has  been 
shown that Ara-C elicits such a differential inhibi- 
tion which directly correlates with increased provi- 
sion  of  the  RNA  templates  which  mediate  GS 
synthesis (15). 
Since both Ara-C and hydrocortisone elicit an 
accumulation of GS-specific RNA templates (15, 
26),  one  might  have  expected to  find a  marked 
increase  in  the  rate  of  GS  synthesis  in  retinas 
treated with either effector; however, this expecta- 
tion proved to he incorrect. In the steroid-induced 
retinas,  immunochemical  determinations  con- 
firmed previous findings (30) that, as the pool of 
GS-specific templates increased, the  rate  of GS 
synthesis was driven upward (Table III). In con- 
trast, it was found that the rate of GS synthesis did 
not  increase  over the  basal level in  the  Ara-C- 
treated retinas (Table III), despite the progressive 
accumulation of templates for GS synthesis (Fig. 3 
and  reference  15).  These  results  suggest  that 
translation  of  GS  templates  is  hindered  in  the 
presence of Ara-C; this possibility is supported by 
the finding that the hindrance can apparently be 
reversed by withdrawing the nucleoside (Fig. 4). 
Thus, in the embryonic retina, the rate of synthe- 
sis of a  specific protein (GS) may not always be 
directly related to the quantity of available tem- 
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tional hindrance caused by Ara-C neither prevents 
the accumulation of GS-specific templates (Fig. 3) 
nor stops the continuous de novo synthesis of the 
enzyme at a basal rate (Tables II and III). That the 
low rate of GS synthesis in Ara-C-treated retinas 
is not due to a defective messenger RNA for GS is 
shown by the fact that, under appropriate experi- 
mental conditions, the  rate  of GS  synthesis can 
increase promptly after withdrawal of Ara-C (Fig. 
4A). 
The nature of the  reversible translational hin- 
drance elicited by  Ara-C is  presently unknown; 
however, the following possibilities suggest them- 
selves:  (a)  Ara-C  may  directly  inactivate some 
component(s) required for optimal translation of 
mRNA for GS; (b) Ara-C may indirectly limit the 
provision of an essential translation factor(s) as a 
consequence of its inhibition of macromolecular 
synthesis; (c) the nucleoside may cause a general 
metabolic reduction of the ATP or GTP pools in 
the retina, thus limiting the rate of translation of 
all mRNA. 
TURNOVER  OF  GS :  Regulation of the  turn- 
over rate of specific proteins is an important con- 
trol  mechanism in eukaryotic  cells  (5,  38,  39). 
Accumulation of newly synthesized enzyme mole- 
cules  reflects  the  balance  between  the  rates  of 
synthesis  and  degradation  of  the  enzyme  (38). 
Our radioimmunoassays have shown that the rate 
of GS synthesis was virtually identical in retinas 
cultured in either the presence or absence of 7.5 
mM Ara-C (Table III); yet, in the Ara-C-treated 
retinas, there was a several-fold greater accumula- 
tion  of  newly  synthesized  GS  than  in  controls 
(Table  II).  The  most  plausible interpretation of 
the  above results is that  treatment of the  retina 
with Ara-C causes cessation of GS turnover, and 
this possibility should eventually lend itself to di- 
rect examination) 
In contrast to Ara-C, HC appears not to halt the 
turnover of GS in the  retina (30); thus, in hor- 
3 Conventional "pulse-chase" experiments for measure- 
ment of protein degradation in the retina are not pre- 
sented in this report since (a) we were unable to deter- 
mine unequivocably the extent of reutilization of 14C- 
amino acids derived from the  breakdown of proteins 
labeled during the initial pulse period; (b) we did not 
wish to use additional drugs to block reutilization of the 
labeled  amino  acids; and  (c)  conclusions concerning 
rates of GS degradation in Ara-C-treated retinas could 
be derived implicitly  by comparing rates of GS synthesis 
with rates of GS accumulation. 
monal  induction,  accumulation  of  GS  is  due 
largely to the increased rate of GS synthesis (Ta- 
ble III and reference 30). These differences with 
respect to GS turnover provide a further example 
of disparities between the  mechanisms by which 
Ara-C and HC elicit increases in the level of GS in 
the retina. 
Studies on the hormonal induction of retinal GS 
have suggested that GS degradation may be me- 
diated by a  degrader molecule which has a  rela- 
tively short half-life and which requires continuous 
RNA synthesis for its production or activity (30). 
The turnover of inducible enzymes in other tissues 
as  well  may be  dependent upon the  continuous 
synthesis and provision of specific  degradative en- 
zymes of short half-life (10, 17, 18, 21-23). In the 
embryonic neural retina, provision of the  postu- 
lated degrader of GS can apparently be stopped by 
completely inhibiting RNA synthesis with Act D 
(26,  30),  or  by  arresting protein synthesis with 
cycloheximide or puromycin (29).  We suggested 
above that  Ara-C elicits accumulation of GS by 
stopping the  turnover of this enzyme; since this 
occurs only at concentrations of Ara-C which se- 
verely inhibit RNA and protein syntheses in the 
retina (14, 15), it is quite possible that the nucleo- 
side inhibits the formation of the labile degrader of 
GS, thereby causing cessation of GS degradation. 
However, an alternative possibility is suggested by 
the  finding that  degradation  of  tyrosine  amino- 
transferase in cultured hepatoma cells is reduced 
by inhibitors of ATP production (11).  As noted 
earlier, Ara-C may reduce ATP levels in the ret- 
ina, and this reduction could account for both the 
cessation of GS turnover and the low rate of GS 
synthesis. Future studies will  attempt  to  resolve 
these alternatives. 
Usefulness  of Ara-C as a Molecular 
Probe of Gene Expression 
The  finding that  Ara-C  may  be  employed to 
elicit increases in retinal GS in the absence of the 
typical steroid inducer of this enzyme can be of 
significant benefit to  further  studies  of  enzyme 
regulation in embryonic cells.  The potential use- 
fulness of Ara-C in this context is evident from the 
facts that  Ara-C is chemically different from the 
inducing corticosteroids  and  causes  increases  in 
the level of GS by a mechanism different from that 
of  steroid  inducers.  An  essential  aspect  of  the 
mechanism of action of Ara-C is that  it inhibits 
both RNA and protein syntheses in the retina in a 
remarkably discriminatory manner: Unlike some 
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synthesis,  Ara-C  does  not  stop  the  formation  of 
RNA templates for GS, yet it blocks the turnover 
of the enzyme. Similarly, cessation of GS turnover 
in Ara-C-treated retinas must be achieved through 
a  mechanism  more  selective  than  that  of  other 
inhibitors of protein synthesis which stop enzyme 
degradation  (3,  17,  21-23):  Ara-C  blocks  GS 
turnover without preventing de novo  synthesis of 
the enzyme; as a  result, GS accumulates continu- 
ously.  In contrast,  cycloheximide  and puromycin 
inhibit both GS degradation  and  GS synthesis in 
the retina,  causing enzyme levels to plateau  (29, 
30). Finally, an additional experimental advantage 
of Ara-C  is  that its effects  on  accumulation  and 
translation of GS template RNA, and on GS deg- 
radation,  are  reversed  if the  nucleoside  is  with- 
drawn  (Fig. 4  and reference  15). 
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